HYPERTENSION RESEARCH

Scope & Guideline

Pioneering research at the intersection of cardiology and physiology.

Introduction

Delve into the academic richness of HYPERTENSION RESEARCH with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0916-9636
PublisherSPRINGERNATURE
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1992 to 2024
AbbreviationHYPERTENS RES / Hypertens. Res.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal 'Hypertension Research' aims to advance our understanding of hypertension through a multidisciplinary approach, integrating basic science, clinical research, and epidemiological studies. It serves as a platform for disseminating innovative findings on the pathophysiology, diagnosis, and treatment of hypertension and its associated complications.
  1. Pathophysiology of Hypertension:
    Investigating the underlying biological mechanisms contributing to hypertension, including genetic, molecular, and environmental factors.
  2. Clinical Management and Treatment Strategies:
    Examining various treatment modalities for hypertension, including pharmacological interventions, lifestyle modifications, and emerging therapies such as renal denervation.
  3. Epidemiological Studies:
    Conducting population-based studies to assess the prevalence, risk factors, and outcomes associated with hypertension across different demographics.
  4. Innovations in Diagnostic Techniques:
    Exploring new methodologies for measuring blood pressure and related parameters, including home monitoring and advanced imaging techniques.
  5. Hypertension and Comorbidities:
    Studying the relationship between hypertension and other health conditions, such as diabetes, cardiovascular diseases, and renal dysfunction.
  6. Public Health Implications:
    Addressing the societal impact of hypertension, including prevention strategies, health policy implications, and healthcare resource management.
In recent years, 'Hypertension Research' has seen a significant increase in interest in several emerging themes. These trends reflect the evolving landscape of hypertension research, with a focus on novel insights and interdisciplinary approaches.
  1. Digital Health and Telemedicine:
    The rise of digital health technologies and telemedicine has become a focal point, exploring their roles in hypertension management, including remote monitoring and mobile health applications.
  2. Genetic and Molecular Mechanisms:
    There is a growing emphasis on understanding the genetic and molecular underpinnings of hypertension, particularly through the use of polygenic risk scores and biomarker studies.
  3. Impact of Lifestyle on Hypertension:
    Research is increasingly focusing on the interplay between lifestyle factors (diet, exercise, sleep) and hypertension, highlighting personalized approaches for prevention and management.
  4. Hypertension in Special Populations:
    Emerging themes include the study of hypertension in specific populations, such as pregnant women, children, and ethnic minorities, to better understand unique risk factors and treatment responses.
  5. Integrated Care Models:
    An increasing trend towards integrated care models that address hypertension in the context of comorbidities, emphasizing a holistic approach to patient management.

Declining or Waning

While 'Hypertension Research' continues to evolve, certain themes have seen a decline in focus over recent years. The following areas are becoming less prominent in the journal's publications, indicating a shift in research priorities.
  1. Traditional Risk Factor Studies:
    Research focusing solely on traditional risk factors for hypertension, such as age, gender, and obesity, has decreased as newer, more complex interactions are explored.
  2. Basic Pharmacological Studies:
    There has been a waning interest in purely pharmacological studies without a translational or clinical application, as the field moves towards integrative approaches that consider patient-specific factors.
  3. Single-Country Studies:
    Research limited to single-country populations is diminishing, with a trend towards multi-national or regional studies that enhance the generalizability of findings.
  4. Static Treatment Guidelines:
    The publication of static treatment guidelines is declining, reflecting a shift towards more dynamic, individualized treatment strategies that adapt to emerging evidence.
  5. Focus on Non-Pharmacological Interventions:
    The emphasis on non-pharmacological interventions alone has decreased, as the integration of lifestyle modifications with pharmacological treatments is increasingly recognized as essential.

Similar Journals

Cardiology in Review

Empowering professionals with essential cardiology insights.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1061-5377Frequency: 6 issues/year

Cardiology in Review, published by Lippincott Williams & Wilkins, is a prominent journal focused on advancing the field of cardiology and cardiovascular medicine. With a history of publication spanning from 1995 to 2024, the journal serves as an essential resource for researchers, healthcare professionals, and students alike, offering in-depth reviews and analyses on the latest developments, clinical practices, and research findings in cardiology. Despite being a traditional print journal, it maintains a commendable Q2 ranking in both cardiology and miscellaneous medicine categories as of 2023, reflecting its influence and rigor in the academic community, with a Scopus rank of #132 out of 387 in its field, placing it in the 66th percentile. The journal aims to bridge the gap between clinical practice and emerging research, promoting a deeper understanding and integration of innovative strategies in cardiovascular care. With its commitment to high-quality scholarship, Cardiology in Review remains a vital conduit for knowledge and dialogue within the evolving landscape of cardiovascular health.

KIDNEY & BLOOD PRESSURE RESEARCH

Innovating Nephrology and Cardiovascular Medicine.
Publisher: KARGERISSN: 1420-4096Frequency: 12 issues/year

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.

BLOOD PRESSURE

Bridging research and practice to elevate health standards.
Publisher: TAYLOR & FRANCIS LTDISSN: 0803-7051Frequency: 6 issues/year

BLOOD PRESSURE is a distinguished journal published by Taylor & Francis Ltd in the field of cardiology and internal medicine, with an ISSN of 0803-7051 and E-ISSN of 1651-1999. Since its inception in 1992, it has become a vital source of research and clinical information, dedicated to advancing our understanding of blood pressure-related health issues. With a notable categorization of Q3 in Cardiology and Cardiovascular Medicine and Q2 in Internal Medicine as of 2023, this journal exemplifies a commitment to evidence-based findings that impact clinical practice and patient care. The journal facilitates a platform for original research, reviews, and case studies, aiming to bridge the gap between researchers and practitioners. Although it does not currently offer open access, BLOOD PRESSURE remains an essential resource for professionals and students alike, striving to enhance health outcomes through dedication to innovative cardiovascular research.

REVISTA ESPANOLA DE CARDIOLOGIA

Transforming Cardiovascular Research into Real-World Impact
Publisher: EDICIONES DOYMA S AISSN: Frequency: 12 issues/year

REVISTA ESPANOLA DE CARDIOLOGIA is a premier journal dedicated to the dynamic field of cardiology, published by EDICIONES DOYMA S A in Barcelona, Spain. With an impressive Q1 status in the Medicine (miscellaneous) category for 2023, this journal is recognized for its significant contributions to cardiovascular research, evidenced by its rank of #61 out of 387 in the Scopus database, placing it within the top 16% of journals in its field. Covering a broad range of topics within cardiology, the journal aims to disseminate high-quality research, clinical studies, and educational content, fostering knowledge sharing among researchers, clinicians, and students alike. While it does not currently offer open access, the journal maintains a commitment to advancing cardiovascular health through rigorous peer-reviewed articles. With a publication history that spans from 2013 to 2024, REVISTA ESPANOLA DE CARDIOLOGIA is an essential resource for those seeking to stay at the forefront of cardiology advancements and practices.

Clinical Hypertension

Unlocking the future of hypertension science.
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Clinical Hypertension is a premier journal dedicated to advancing the field of hypertension and cardiovascular health, published by SpringerNature. Since its transition to an Open Access model in 2014, the journal has opened doors for researchers globally to share their findings without barriers, aiming to foster collaboration and innovation in this vital area of medicine. With a current impact factor that positions it in the Q2 quartile for both Cardiology and Cardiovascular Medicine and Internal Medicine, Clinical Hypertension is recognized for its scholarly contributions, reflected in its Scopus rankings (Rank #100/387 in Cardiology and Rank #52/167 in Internal Medicine), which place it in the top percentiles of these competitive fields. Covering a diverse range of topics within hypertension research, it serves as an essential resource for clinicians, researchers, and students alike, promising to keep its audience informed of the latest developments and breakthroughs from its inception in 2017 through to 2024.

Asian Biomedicine

Illuminating the Path of Biomedical Advancements
Publisher: WALTER DE GRUYTER GMBHISSN: 1905-7415Frequency: 6 issues/year

Asian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.

Current Hypertension Reviews

Shaping the Future of Hypertension Studies
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-4021Frequency:

Current Hypertension Reviews, published by Bentham Science Publishers Ltd, stands as a leading journal in the field of internal medicine, particularly focusing on hypertension and related cardiovascular disorders. With an impressive impact factor and ranked #59 out of 167 in the Scopus medicine category, this journal highlights key insights and contemporary research trends from its inception in 2006 to 2024. Its commitment to making high-quality research accessible to the medical community, despite lacking an Open Access option, ensures that it continues to contribute significantly to the scientific discourse surrounding hypertension management and innovative treatments. Researchers, clinicians, and students alike will find valuable resources within its pages, as Current Hypertension Reviews plays a critical role in advancing the understanding and treatment of hypertension, ultimately supporting better health outcomes globally.

Journal of Cardiology

Pioneering research to transform cardiology practices.
Publisher: ELSEVIERISSN: 0914-5087Frequency: 12 issues/year

Journal of Cardiology, published by ELSEVIER, stands as a prominent resource in the field of cardiology and cardiovascular medicine. With a rich history since its inception in 1987, this peer-reviewed journal aims to disseminate cutting-edge research that enhances the understanding and treatment of cardiovascular diseases. Its 2023 ranking places it in the Q2 category within its discipline, reflecting its significance and impact, as evidenced by a Scopus rank of #123 out of 387 journals, positioning it in the 68th percentile of its field. The journal is headquartered in Japan, providing a unique perspective on cardiological advances relevant not only to the Asian continent but also globally. Though it does not currently offer open access, the Journal of Cardiology remains a vital institutional resource for researchers, clinicians, and students seeking to push the boundaries of cardiovascular science and improve patient outcomes.

International Journal of Hypertension

Innovating solutions for better cardiovascular outcomes.
Publisher: HINDAWI LTDISSN: 2090-0384Frequency: 1 issue/year

The International Journal of Hypertension, published by HINDAWI LTD, is a pivotal open-access journal dedicated to advancing knowledge in the field of hypertension and cardiovascular health. Since its inception in 2010, the journal has provided a vital platform for researchers, clinicians, and students to disseminate innovative findings and comprehensive reviews spanning various aspects of hypertension management, pathophysiology, and epidemiology. Residing in Q3 of the Internal Medicine category and ranked 75 out of 167 in the Scopus rankings, it reflects a commitment to quality and relevance in medical research. With a global reach, the journal aims to foster collaboration and knowledge exchange, contributing significantly to the scientific community's efforts to combat hypertension-related health issues. Accessible since 2010, this journal exemplifies the principles of open science, ensuring that critical research is available to all stakeholders in the field.

Cardiology Research and Practice

Empowering the global community with cutting-edge cardiology studies.
Publisher: HINDAWI LTDISSN: 2090-8016Frequency: 1 issue/year

Cardiology Research and Practice is a leading academic journal dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by HINDAWI LTD, this journal has been an inclusive platform for open access research since 2009, facilitating the dissemination of high-quality studies that contribute to the global scientific community. With an impact factor placing it in Q2 of its category in 2023, it underscores its importance in delivering innovative insights and discoveries that shape clinical practices and policies. The journal covers a broad scope of topics including, but not limited to, cardiovascular disease prevention, innovative treatment modalities, and emerging technologies, appealing to researchers, healthcare professionals, and students alike. Located in the United States with its international reach, Cardiology Research and Practice serves as a critical resource for those dedicated to improving patient outcomes and advancing the field of cardiology.